Ameriprise’s Inventiva IVA Stock Holding History

Ameriprise’s Portfolio IVA Stock Details IVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.42M	Buy	1,697,148 +852,933	+101%	+$4.1M	﹤0.01%	2380
2026 Q1	$4.69M	Buy	844,215 +228,742	+37%	+$1.39M	﹤0.01%	2470
2025 Q4	$2.86M	Buy	+615,473	New	+$2.86M	﹤0.01%	2809

Other funds holding IVA

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Andera Partners Paris $206M AUM

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Ameriprise's IVA Position: Q2 2026 in Review

Ameriprise increased its Inventiva (IVA) stake by 101% in Q2 2026, buying an estimated $4.1M and bringing the position to 1,697,148 shares worth $6.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2380.

Ameriprise first reported a position in IVA in Q4 2025 and has held it in 3 quarters since. 88 funds tracked by Wall St. Rank hold IVA as of Q2 2026.

Ameriprise held 1,697,148 shares of Inventiva worth $6.42M as of Q2 2026.
Ameriprise bought 852,933 Inventiva shares in Q2 2026, an estimated $4.1M.
Inventiva made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2380 holding.
Ameriprise first reported a position in Inventiva in Q4 2025 and has held it in 3 quarters since.
88 funds tracked by Wall St. Rank held Inventiva as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.